Overall , 24 serious adverse events were reported in 15 patients ( PET responders : nine events in four [ 6 % ] of 67 patients ; group A : 14 events in ten [ 21 % ] of 47 patients ; group B : one event in one [ 4 % ] of 25 patients ) .